作者
- Granger, C.B. (6)
- Hall, C. (5)
- Maggioni, A.P. (6)
- McMurray, J.J.V. (7)
- Packer, M. (5)
- Pfeffer, M.A. (11)
- Rouleau, J.L. (24)
- Sirois, P. (4)
- Swedberg, K. (6)
- Yusuf, S. (4)
|
總筆數:24
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Absence of a deleterious effect of calcium channel blockers in patientswith left ventricular dysfunction after myocardial infarction: The SAVEstudy experience |
For the SAVE Investigators;Hager, W.;Davis, B.R.;Riba, A.;Moye, L.A.;Wun, C.C.;Rouleau, J.L.;Lamas, G.A.;Pfeffer, M.A.; |
American Heart Journal |
1998-03-01 |
查看 |
| Absence of a deleterious effect of calcium channel blockers in patientswith left ventricular dysfunction after myocardial infarction: The SAVEstudy experience |
For the SAVE Investigators;Hager, W.;Davis, B.R.;Riba, A.;Moye, L.A.;Wun, C.C.;Rouleau, J.L.;Lamas, G.A.;Pfeffer, M.A.; |
American Heart Journal |
1998-03-01 |
查看 |
| Neurohormonal activation in severe heart failure: Relations to patientdeath and the effect of treatment with flosequinan |
Moe, G.W.;Rouleau, J.L.;Charbonneau, L.;Proulx, G.;Arnold, J.M.O.;Hall, C.;de Champlain, J.;Barr, A.;Sirois, P.;Packer, M.;Candian PROFILE investigators; |
American Heart Journal |
2000-04-01 |
查看 |
| Regional wall stress predicts ventricular remodeling after anteroseptalmyocardial infarction in the Healing and Early Afterload Reducing Trial(HEART): An echocardiography-based structural analysis |
Aikawa, Y.;Rohde, L.;Plehn, J.;Greaves, S.C.;Menapace, F.;Arnold, J.O.;Rouleau, J.L.;Pfeffer, M.A.;Lee, R.T.;Solomon, S.D.; |
American Heart Journal |
2001-02-01 |
查看 |
| The continuation of the Prevention of Events WithAngiotensin-Converting Enzyme Inhibition (PEACE) Trial |
for the PEACE Investigators;Pfeffer, M.A.;Domanski, M.;Verter, J.;Dunlap, M.;Flaker, G.C.;Gersh, B.;Hsia, J.;Goldberg, A.;Limacher, M.C.;Maggioni, A.P.;Rosenberg, Y.;Rouleau, J.L.;Warnica, J.;Wasserman, A.G.;Braunwald, E.; |
American Heart Journal |
2001-09-01 |
查看 |
| The continuation of the Prevention of Events WithAngiotensin-Converting Enzyme Inhibition (PEACE) Trial |
Pfeffer, M.A.;Domanski, M.;Verter, J.;Dunlap, M.;Flaker, G.C.;Gersh, B.;Hsia, J.;Goldberg, A.;Limacher, M.C.;Maggioni, A.P.;Rosenberg, Y.;Rouleau, J.L.;Warnica, J.;Wasserman, A.G.;Braunwald, E.;for the PEACE Investigators; |
American Heart Journal |
2001-09-01 |
查看 |
| Changes in vasoconstrictive hormones, natriuretic peptides, and leftventricular remodeling soon after anterior myocardial infarction |
White, M.;Rouleau, J.L.;Hall, C.;Arnold, M.;Harel, F.;Sirois, P.;Greaves, S.;Solomon, S.;Ajani, U.;Glynn, R.;Hennekens, C.;Pfeffer, M.; |
American Heart Journal |
2001-12-01 |
查看 |
| Changes in vasoconstrictive hormones, natriuretic peptides, and leftventricular remodeling soon after anterior myocardial infarction |
White, M.;Rouleau, J.L.;Hall, C.;Arnold, M.;Harel, F.;Sirois, P.;Greaves, S.;Solomon, S.;Ajani, U.;Glynn, R.;Hennekens, C.;Pfeffer, M.; |
American Heart Journal |
2001-12-01 |
查看 |
| Changes in vasoconstrictive hormones, natriuretic peptides, and leftventricular remodeling soon after anterior myocardial infarction |
White, M.;Rouleau, J.L.;Hall, C.;Arnold, M.;Harel, F.;Sirois, P.;Greaves, S.;Solomon, S.;Ajani, U.;Glynn, R.;Hennekens, C.;Pfeffer, M.; |
American Heart Journal |
2001-12-01 |
查看 |
| Prognostic importance of the oxidized product of catecholamines,adrenolutin, in patients with severe heart failure |
Rouleau, J.L.;Pitt, B.;Dhalla, N.S.;Dhalla, K.S.;Swedberg, K.;Hansen, M.S.;Stanton, E.;Lapointe, N.;Packer, M.;Canadian Prospective RandOmized FlosequInan Longevity Evaluation (PROFILE);Investigators; |
American Heart Journal |
2003-05-01 |
查看 |
| Prognostic importance of the oxidized product of catecholamines,adrenolutin, in patients with severe heart failure |
Rouleau, J.L.;Pitt, B.;Dhalla, N.S.;Dhalla, K.S.;Swedberg, K.;Hansen, M.S.;Stanton, E.;Lapointe, N.;Packer, M.;Canadian Prospective RandOmized FlosequInan Longevity Evaluation (PROFILE);Investigators; |
American Heart Journal |
2003-05-01 |
查看 |
| Neurohormones and oxidative stress in nonischemic cardiomyopathy:relationship to survival and the effect of treatment with amlodipine |
Wijeysundera, H.C.;Hansen, M.S.;Stanton, E.;Cropp, A.S.;Hall, C.;Dhalla, N.S.;Ghali, J.;Rouleau, J.L.;PRAISE II Investigators; |
American Heart Journal |
2003-08-01 |
查看 |
| Prognostic use of echocardiography 1 year after a myocardial infarction |
for the Survival and Ventricular Enlargement (SAVE) Investigators;Skali, H.;Zornoff, L.A.M.;Pfeffer, M.A.;Arnold, M.O.;Lamas, G.A.;Moye, L.A.;Plappert, T.;Rouleau, J.L.;Sussex, B.A.;St John Sutton, M.;Braunwald, E.;Solomon, S.D.; |
American Heart Journal |
2005-10-01 |
查看 |
| Are @b-blockers needed in patients receiving spironolactone for severechronic heart failure? An analysis of the COPERNICUS study |
for the Carvedilol Prospective Randomized Cumulative Survival;(COPERNICUS) Study Group;Krum, H.;Mohacsi, P.;Katus, H.A.;Tendera, M.;Rouleau, J.L.;Fowler, M.B.;Coats, A.J.;Roecker, E.B.;Packer, M.; |
American Heart Journal |
2006-01-01 |
查看 |
| The cost of acute myocardial infarction in the new millennium: Evidencefrom a multinational registry |
Kauf, T.L.;Velazquez, E.J.;Crosslin, D.R.;Weaver, W.D.;Diaz, R.;Granger, C.B.;McMurray, J.J.V.;Rouleau, J.L.;Aylward, P.E.;White, H.D.;Califf, R.M.;Schulman, K.A.; |
American Heart Journal |
2006-01-01 |
查看 |
| Are @b-blockers needed in patients receiving spironolactone for severechronic heart failure? An analysis of the COPERNICUS study |
for the Carvedilol Prospective Randomized Cumulative Survival;(COPERNICUS) Study Group;Krum, H.;Mohacsi, P.;Katus, H.A.;Tendera, M.;Rouleau, J.L.;Fowler, M.B.;Coats, A.J.;Roecker, E.B.;Packer, M.; |
American Heart Journal |
2006-01-01 |
查看 |
| The cost of acute myocardial infarction in the new millennium: Evidencefrom a multinational registry |
Kauf, T.L.;Velazquez, E.J.;Crosslin, D.R.;Weaver, W.D.;Diaz, R.;Granger, C.B.;McMurray, J.J.V.;Rouleau, J.L.;Aylward, P.E.;White, H.D.;Califf, R.M.;Schulman, K.A.; |
American Heart Journal |
2006-01-01 |
查看 |
| Prevention of atrial fibrillation in patients with symptomatic chronicheart failure by candesartan in the Candesartan in Heart failure:Assessment of Reduction in Mortality and morbidity (CHARM) program |
Ducharme, A.;Swedberg, K.;Pfeffer, M.A.;Cohen-Solal, A.;Granger, C.B.;Maggioni, A.P.;Michelson, E.L.;McMurray, J.J.V.;Olsson, L.;Rouleau, J.L.;Young, J.B.;Yusuf, S.; |
American Heart Journal |
2006-05-01 |
查看 |
| Angiotensin-converting enzyme inhibition in patients with coronaryartery disease and preserved left ventricular function |
On behalf of the IMAGINE Investigators;van Gilst, W.H.;Warnica, J.W.;Baillot, R.;Johnstone, D.;Calciu, C.D.;Block, P.;Myers, M.G.;Chocron, S.;Rouleau, J.L.; |
American Heart Journal |
2006-06-01 |
查看 |
| Angiotensin-converting enzyme inhibition in patients with coronaryartery disease and preserved left ventricular function |
On behalf of the IMAGINE Investigators;van Gilst, W.H.;Warnica, J.W.;Baillot, R.;Johnstone, D.;Calciu, C.D.;Block, P.;Myers, M.G.;Chocron, S.;Rouleau, J.L.; |
American Heart Journal |
2006-06-01 |
查看 |
| Prevention of atrial fibrillation in patients with symptomatic chronicheart failure by candesartan in the Candesartan in Heart failure:Assessment of Reduction in Mortality and morbidity (CHARM) program |
on behalf of the CHARM Investigators;Ducharme, A.;Swedberg, K.;Pfeffer, M.A.;Cohen-Solal, A.;Granger, C.B.;Maggioni, A.P.;Michelson, E.L.;McMurray, J.J.V.;Olsson, L.;Rouleau, J.L.;Young, J.B.;Olofsson, B.;Puu, M.;Yusuf, S.; |
American Heart Journal |
2006-07-01 |
查看 |
| Prevention of atrial fibrillation in patients with symptomatic chronicheart failure by candesartan in the Candesartan in Heart failure:Assessment of Reduction in Mortality and morbidity (CHARM) program |
on behalf of the CHARM Investigators;Ducharme, A.;Swedberg, K.;Pfeffer, M.A.;Cohen-Solal, A.;Granger, C.B.;Maggioni, A.P.;Michelson, E.L.;McMurray, J.J.V.;Olsson, L.;Rouleau, J.L.;Young, J.B.;Olofsson, B.;Puu, M.;Yusuf, S.; |
American Heart Journal |
2006-07-01 |
查看 |
| Prevention of atrial fibrillation in patients with symptomatic chronicheart failure by candesartan in the Candesartan in Heart failure:Assessment of Reduction in Mortality and morbidity (CHARM) program |
on behalf of the CHARM Investigators;Ducharme, A.;Swedberg, K.;Pfeffer, M.A.;Cohen-Solal, A.;Granger, C.B.;Maggioni, A.P.;Michelson, E.L.;McMurray, J.J.V.;Olsson, L.;Rouleau, J.L.;Young, J.B.;Olofsson, B.;Puu, M.;Yusuf, S.; |
American Heart Journal |
2006-07-01 |
查看 |
| Cardiac structure and function, remodeling, and clinical outcomes amongpatients with diabetes after myocardial infarction complicated by leftventricular systolic dysfunction, heart failure, or both |
Shah, A.M.;Hung, C.L.;Shin, S.H.;Skali, H.;Verma, A.;Ghali, J.K.;Kober, L.;Velazquez, E.J.;Rouleau, J.L.;McMurray, J.J.V.;Pfeffer, M.A.;Solomon, S.D.; |
American Heart Journal |
2011-10-01 |
查看 |
|
|
|
